Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites

Biomedical Chromatography

Volumn 25, Issue 1, 2011, Pages 238-257

  Unceta, Nora ^a   Goicolea, M Aranzazu ^a   Barrio, Ramón J ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Analytical method; Biological samples; Citalopram; Enantiomers; Environmental samples; Metabolites; Sample pre treatment

Indexed keywords

BIOMOLECULES; CAPILLARY ELECTROPHORESIS; DRUG PRODUCTS; ENANTIOMERS; EXTRACTION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHASE SEPARATION;

ANALYTICAL METHOD; ANALYTICAL PROCEDURE; BIOLOGICAL SAMPLES; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEMS; CITALOPRAM; ENVIRONMENTAL SAMPLE; OBSESSIVE-COMPULSIVE DISORDERS; SAMPLE PRETREATMENT; SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS;

METABOLITES;

AMFEBUTAMONE; AMITRIPTYLINE; BETA CYCLODEXTRIN; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; CLOZAPINE; DESIPRAMINE; DESMETHYLMIRTAZAPINE; DESVENLAFAXINE; DOXEPIN; DRUG METABOLITE; DULOXETINE; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; IMIPRAMINE; LETROZOLE; MAPROTILINE; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; NORCLOMIPRAMINE; NORFLUOXETINE; NORMAPROTILINE; NORSERTRALINE; NORTRIPTYLINE; SERTRALINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALYTIC METHOD; CAPILLARY ELECTROPHORESIS; CHIRAL CHROMATOGRAPHY; DRUG DETERMINATION; ENANTIOMER; EXTRACTION; FLUORESCENCE SPECTROSCOPY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; REVIEW; SENSITIVITY ANALYSIS; SOLID PHASE EXTRACTION; SOLID PHASE MICROEXTRACTION; STEREOCHEMISTRY; ULTRAVIOLET SPECTROSCOPY;

EID: 78650660636     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1542     Document Type: Review

References (135)

1. Akerman KK, Jolkkonen J, Huttunen H and Penttila I. High-performance liquid chromatography method for analyzing citalopram and desmethylcitalopram from human serum. Therapeutic Drug Monitoring 1998; 20: 25-29.
2. Al-Ghazawi M, Tutunji M, Mohsen M and Najjar S. Pharmacokinetic comparison of two 40 mg tablet formulations of citalopram using a new amperometric detection technique. International Journal of Clinical Pharmacology and Therapeutics 2007; 45: 300-306.
3. Andersen S, Halvorsen TG, Pedersen-Bjergaard S, Rasmussen KE, Tanum L and Refsum H. Stereospecific determination of citalopram and desmethylcitalopram by capillary electrophoresis and liquid-phase microextraction. Journal of Pharmaceutical and Biomedical Analysis 2003; 33: 263-273.
4. Arthur CL and Pawliszyn J. Solid phase microextraction with thermal desorption using fused silica optical fibers. Analytical Chemistry 1990; 62: 2145-2148.
5. Bagheri H, Khalilian F, Babanezhad E, Es-Haghi A and Rouini M-R. Modified solvent microextraction with back extraction combined with liquid chromatography-fluorescence detection for the determination of citalopram in human plasma. Analytica Chimica Acta 2008; 610: 211-216.
6. Baumann P and Larsen F. The pharmacokinetics of citalopram. Reviews in Contemporary Pharmacotherapy 1995; 6: 287-295.
7. Baumann P and Rochat B. Comparative pharmacokinetics of selective serotonin reuptake inhibitors-a look behind the mirror. International Clinical Psychopharmacology 1995; 10: 15-21.
8. Berzas JJ, Guiberteau C, Contento AM and Rodriguez V. Sensitive and rapid high-performance liquid chromatographic method for simultaneous determination of antidepressants in pharmaceutical formulations. Chromatographia 2002; 56: 545-551.
9. Berzas JJ, Guiberteau C, Villasenor MJ and Rodriguez V. Development of a capillary gas chromatographic procedure. Analytica Chimica Acta 2004; 519: 219-230.
10. Berzas-Nevado JJ, Villasenor-Llerena MJ, Guiberteau-Cabanillas C and Rodriguez-Robledo V. Enantiomeric screening of racemic citalopram and metabolites in human urine by entangled polymer solution capillary electrophoresis: an innovatory robustness/ruggedness study. Electrophoresis 2006; 27: 905-917.
11. Bush LR, Currie MG, Senanayake CH and Fang KQ. Methods for treating depression and other CNS disorders using enantiomerically enriched desmethyl- and didesmethyl- metabolites of citalopram. (Sepracor, Inc.) WO 2003/040121 A1, 2003. Chem. Abstr. 2003; 138: 376842.
12. Buzinkaiova T and Polonsky J. Determination of four selective serotonin reuptake inhibitors by capillary isotachophoresis. Electrophoresis 2000; 21: 2839-2841.
13. Cao X-q, Chen X-y, Zhang Y-f and Zhong D-f. Determination of citalopram in human plasma with LC-MS/MS method and its bioequivalent evaluation. Yao Xue Xue Bao 2007; 42: 450-454.
14. Carlsson B and Norlander B. Solid-phase extraction with end-capped C-2 columns for the routine measurement of racemic citalopram and metabolites in plasma by high-performance liquid chromatography. Journal of Chromatography, B 1997; 702: 234-239.
15. Carlsson B and Norlander B. Optimization and characterization of the chiral separation of citalopram and its demethylated metabolites by response-surface methodology. Chromatographia 2001; 53: 266-272.
16. Carlsson B, Holmgren A, Ahlner J and Bengtsson F. Enantioselective analysis of citalopram and escitalopram in postmortem blood together with genotyping for CYP2D6 and CYP2C19. Journal of Analytical Toxicology 2009; 33: 65-76.
17. Catai APF, Carrilho E, Lancas FM and Queiroz MEC. Fast separation of selective serotonin reuptake inhibitors antidepressants in plasma sample by nonaqueous capillary electrophoresis. Journal of Chromatography, A 2009; 1216: 5779-5782.
18. Chaves AR, Silva SM, Queiroz RHC, Lancas FM and Queiroz MEC. Stir bar sorptive extraction and liquid chromatography with UV detection for determination of antidepressants in plasma samples. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2007; 850: 295-302.
19. Chaves AR, Chiericato Junior G and Queiroz MEC. Solid-phase microextraction using poly(pyrrole) film and liquid chromatography with UV detection for analysis of antidepressants in plasma samples. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2009; 877: 587-593.
20. Crifasi JA, Bruder MF, Long CW and Janssen K. Performance evaluation of thermal desorption system (TDS) for detection of basic drugs in forensic samples by GC-MS. Journal of Analytical Toxicology 2006; 30: 581-592.
21. Dalgaard L and Larsen C. Metabolism and excretion of citalopram in man: identification of O-acyl- and N-glucuronides. Xenobiotica 1999; 29: 1033-1041.
22. Dallet P, Labat L, Richard M, Langlois MH and Dubost JP. A reversed-phase HPLC method development for the separation of new antidepressants. Journal of Liquid Chromatography & Related Technologies 2002; 25: 101-111.
23. Dams R, Benijts T, Lambert WE and De Leenheer AP. Simultaneous determination of in total 17 opium alkaloids and opioids in blood and urine by fast liquid chromatography-diode-array detection-fluorescence detection, after solid-phase extraction. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2002; 773: 53-61.
24. Daughton CG and Ternes TA. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environmental Health Perspectives Supplements 1999; 107: 907-938.
25. de Castro A, Femandez M, Laloup M, Samyn N, De Boeck G, Wood M, Maes V and Lopez-Rivadulla M. High-throughput on-line solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of 14 antidepressants and their metabolites in plasma. Journal of Chromatography, A 2007; 1160: 3-12.
26. de Castro A, Concheiro M, Quintela O, Cruz A and Lopez-Rivadulla M. LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma-study of correlation between venlafaxine concentrations in both matrices. Journal of Pharmaceutical and Biomedical Analysis 2008; 48: 183-193.
27. Demeestere K, Petrovic M, Gros M, Dewulf J, Van Langenhove H and Barcelo D. Trace analysis of antidepressants in environmental waters by molecularly imprinted polymer-based solid-phase extraction followed by ultra-performance liquid chromatography coupled to triple quadrupole mass spectrometry. Analytical and Bioanalytical Chemistry 2010; 396: 825-837.
28. De Vane CL. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cellular and Molecular Neurobiology 1999; 19: 443-466.
29. Duverneuil C, de la Grandmaison GL, de Mazancourt P and Alvarez JC. A high-performance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs. Therapeutic Drug Monitoring 2003; 25: 565-573.
30. Eap CB, Bouchoux G, Amey M, Cochard N, Savary L and Baumann P. Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry. Journal of Chromatographic Science 1998; 36: 365-371.
31. El-Gindy A, Emara S, Mesbah MK and Hadad GM. Liquid chromatography determination of citalopram enantiomers using beta-cyclodextrin as a chiral mobile phase additive. Journal of AOAC International 2006; 89: 65-70.
32. El-Rjoob AW, Tahtamouni M and Tahboub YR. Simultaneous Analysis of Fluoxetine, Norfluoxetine, Citalopram, and Haloperidol in Plasma by LC-ESI-IT-MS. Chromatographia 2010; 71: 423-430.
33. Erve JCL, Beyer CE, Manzino L and Talaat RE. Metabolite identification in rat brain microdialysates by direct infusion nanoelectrospray ionization after desalting on a ZipTip and LTQ/Orbitrap mass spectrometry. Rapid Communications in Mass Spectrometry 2009; 23: 4003-4012.
34. Fick J, Soderstrom H, Lindberg RH, Phan C, Tysklind M and Larsson DGJ. Contamination of surface, ground, and drinking water from pharmaceutical production. Environmental Toxicology and Chemistry 2009; 28: 2522-2527.
35. Flores JR, Nevado JJB, Salcedo AMC and Diaz MPC. Development of a capillary zone electrophoretic method to determine six antidepressants in their pharmaceutical preparations. Experimental design for evaluating the ruggedness of method. Journal of Separation Science 2004; 27: 33-40.
36. Flores JR, Salcedo AMC, Llerena MJV and Fernandez LM. Micellar electrokinetic chromatographic method for the determination of letrozole, citalopram and their metabolites in human urine. Journal of Chromatography, A 2008; 1185: 281-290.
37. Frahnert C, Rao ML and Grasmader K. Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2003; 794: 35-47.
38. Frison G, Favretto D, Vogliardi S, Terranova C and Ferrara SD. Quantification of citalopram or escitalopram and their demethylated metabolites in neonatal hair samples by liquid chromatography-tandem mass spectrometry. Therapeutic Drug Monitoring 2008; 30: 467-473.
39. Gandhi SV, Dhavale ND, Jadhav VY and Sabnis SS. Spectrophotometric and reversed-phase high-performance liquid chromatographic methods for simultaneous determination of escitalopram oxalate and clonazepam in combined tablet dosage form. Journal of AOAC International 2008; 91: 33-38.
40. Gondova T, Halamova D and Spacayova K. Simultaneous analysis of new antidepressants by densitometric thin-layer chromatography. Journal of Liquid Chromatography & Related Technologies 2008; 31: 2429-2441.
41. Greiner C, Hiemke C, Bader W and Haen E. Determination of citalopram and escitalopram together with their active main metabolites desmethyl(es-)citalopram in human serum by column-switching high performance liquid chromatography (HPLC) and spectrophotometric detection. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2007; 848: 391-394.
42. Gunnar T, Mykkanen S, Ariniemi K and Lillsunde P. Validated semiquantitative/quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2004; 806: 205-219.
43. Gutierrez MM and Abramowitz W. Pharmacokinetic comparison of oral solution and tablet formulations of citalopram: a single-dose, randomized, crossover study. Clinical Therapeutics 2000; 22: 1525-1532.
44. Gutteck U and Rentsch KM. Therapeutic drug monitoring of 13 antidepressant and five neuroleptic drugs in serum with liquid chromatography-electrospray ionization mass spectrometry. Clinical Chemistry and Laboratory Medicine 2003; 41: 1571-1579.
45. Halvorsen TG, Pedersen-Bjergaard S and Rasmussen KE. Liquid-phase microextraction and capillary electrophoresis of citalopram, an antidepressant drug. Journal of Chromatography, A 2001; 909: 87-93.
46. Haupt D. Determination of citalopram enantiomers in human plasma by liquid chromatographic separation on a Chiral-AGP column. Journal of Chromatography, B: Biomedical Applications 1996; 685: 299-305.
47. He J, Zhou ZL and Li HD. Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI). Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2005; 820: 33-39.
48. Holmgren P, Carlsson B, Zackrisson AL, Lindblom B, Dahl ML, Scordo MG, Druid H and Ahlner J. Enantioselective analysis of citalopram and its metabolites in postmortem blood and genotyping for CYD2D6 and CYP2C19. Journal of Analytical Toxicology 2004; 28: 94-104.
49. Hyttel J, Bogeso KP, Perregaard J and Sanchez C. The Pharmacological Effect of Citalopram Resides in the (S)-(+)-Enantiomer. Journal of Neural Transmission 1992; 88: 157-160.
50. Jiang T, Rong ZX, Peng L, Chen B, Xie YF, Chen CY, Sun J, Xu YP, Lu Y and Chen HZ. Simultaneous determination of citalopram and its metabolite in human plasma by LC-MS/MS applied to pharmacokinetic study. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2010; 878: 615-619.
51. Kirchherr H and Kuhn-Velten WN. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2006; 843: 100-113.
52. Kollroser M and Schober C. An on-line solid phase extraction-liquid chromatography-tandem mass spectrometry method for the analysis of citalopram, fluvoxamine, and paroxetine in human plasma. Chromatographia 2003; 57: 133-138.
53. Kosel M, Eap CB, Amey M and Baumann P. Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography. Journal of Chromatography, B 1998; 719: 234-238.
54. Kristoffersen L, Bugge A, Lundanes E and Slordal L. Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection. Journal of Chromatography, B 1999; 734: 229-246.
55. Kwon JW and Armbrust KL. Degradation of citalopram by simulated sunlight. Environmental Toxicology and Chemistry 2005; 24: 1618-1623.
56. Labat L, Deveaux M, Dallet P and Dubost JP. Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography. Journal of Chromatography, B 2002; 773: 17-23.
57. Lacassie E, Gaulier JM, Marquet P, Rabatel JF and Lachatre G. Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography. Journal of Chromatography, B 2000; 742: 229-238.
58. Lai C-K, Lee T, Au K-m and Chan AY-W. Uniform solid-phase extraction procedure for toxicological drug screening in serum and urine by HPLC with photodiode-array detection. Clinical Chemistry 1997; 43: 312-325.
59. Lajeunesse A, Gagnon C and Sauve S. Determination of basic antidepressants and their n-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography-tandem mass spectrometry. Analytical Chemistry 2008; 80: 5325-5333.
60. Liu X, Su Y, Gan X, Gong P, Duan C and Zhang Y. Evaluating and comparing the intestine permeability of 5 kinds of drugs by everted intestinal sac method. Zhongguo Yaofang 2009; 20: 1704-1706.
61. Macek J, Ptacek P and Klima J. Rapid determination of citalopram in human plasma by high-performance liquid chromatography. Journal of Chromatography, B 2001; 755: 279-285.
62. MacLeod SL, Sudhir P and Wong CS. Stereoisomer analysis of wastewater-derived beta-blockers, selective serotonin re-uptake inhibitors, and salbutamol by high-performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography, A 2007; 1170: 23-33.
63. Malfara WR, Bertucci C, Queiroz MEC, Carvalho SAD, Bianchi MDP, Cesarino EJ, Crippa JA and Queiroz RHC. Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressants. Journal of Pharmaceutical and Biomedical Analysis 2007; 44: 955-962.
64. Mandrioli R, Fanali S, Pucci V and Raggi MA. Enantiomeric separation of citalopram and its metabolites by capillary electrophoresis. Electrophoresis 2003; 24: 2608-2616.
65. Martinez MA, de la Torre CS and Almarza E. A comparative solid-phase extraction study for the simultaneous determination of fluvoxamine, mianserin, doxepin, citalopram, paroxetine, and etoperidone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection. Journal of Analytical Toxicology 2004; 28: 174-180.
66. Matsui E, Hoshino M, Matsui A and Okahira A. Simultaneous determination of citalopram and its metabolites by high-performance liquid chromatography with column switching and fluorescence detection by direct plasma injection. Journal of Chromatography, B: Biomedical Applications 1995; 668: 299-307.
67. Melo LR, Nogueira AM, Lancas FM and Queiroz MEC. Polydimethylsiloxane/polypyrrole stir bar sorptive extraction and liquid chromatography (SBSE/LC-UV) analysis of antidepressants in plasma samples. Analytica Chimica Acta 2009; 633: 57-64.
68. Mendes GD, Borges NCD, Pereira AD, Mendes FD, Barrientos-Astigarraga RE and De Nucci G. A bioequivalence study of citalopram based on quantification by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. International Journal of Clinical Pharmacology and Therapeutics 2005; 43: 389-398.
69. Menegola J, Steppe M and Schapoval EES. Development and validation of column high-performance liquid chromatographic and ultraviolet spectrophotometric methods for citalopram in tablets. Journal of AOAC International 2008; 91: 52-58.
70. Meng QH and Gauthier D. Simultaneous analysis of citalopram and desmethylcitalopram by liquid chromatography with fluorescence detection after solid-phase extraction. Clinical Biochemistry 2005; 38: 282-285.
71. Metcalfe CD, Chu SG, Judt C, Li HX, Oakes KD, Servos MR and Andrews DM. Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed. Environmental Toxicology and Chemistry 2010; 29: 79-89.
72. Millan S, Goicolea MA, Sanchez A, Gomez-Caballero A, Sampedro MC, Unceta N and Barrio RJ. Stereoselective determination of demethyl- and didemethyl-citalopram in rat plasma and brain tissue by liquid chromatography with fluorescence detection using precolumn derivatization. Biomedical Chromatography 2008; 22: 265-271.
73. Molander P, Thomassen A, Kristoffersen L, Greibrokk T and Lundanes E. Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma by temperature-programmed packed capillary liquid chromatography with on-column focusing of large injection volumes. Journal of Chromatography, B 2002; 766: 77-87.
74. Mork A, Kreilgaard M and Sanchez C. The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats. Neuropharmacology 2003; 45: 167-173.
75. Muller C, Vogt S, Goerke R, Kordon A and Weinmann W. Identification of selected psychopharmaceuticals and their metabolites in hair by LC/ESI-CID/MS and LC/MS/MS. Forensic Science International 2000; 113: 415-421.
76. Nevado JJB, Cabanillas CG, Llerena MJV and Robledo VR. Enantiomeric determination, validation and robustness studies of racemic citalopram in pharmaceutical formulations by capillary electrophoresis. Journal of Chromatography, A 2005; 1072: 249-257.
77. Nevado JJB, Llerena MJV, Cabanillas CG and Robledo VR. Screening of citalopram, fluoxetine and their metabolites in human urine samples by gas chromatography-mass spectrometry-a global robustness/ruggedness study. Journal of Chromatography, A 2006a; 1123: 130-133.
78. Nevado JJB, Llerena MJV, Cabanillas CG, Robledo VR and Buitrago S. Sensitive capillary GC-MS-SIM determination of selective serotonin reuptake inhibitors: reliability evaluation by validation and robustness study. Journal of Separation Science 2006b; 29: 103-113.
79. Nielsen MKK, Johansen SS, Dalsgaard PW and Linnet K. Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC-TOF-MS. Forensic Sci. Int. 2010; 196: 85-92.
80. Oeyehaug E, Oestensen ET and Salvesen B. Determination of the antidepressant agent citalopram and metabolites in plasma by liquid chromatography with fluorescence detection. Journal of Chromatography, B: Biomedical Applications 1982; 227: 129-135.
81. Oeyehaug E, Oestensen ET and Salvesen B. High-performance liquid chromatographic determination of citalopram and four of its metabolites in plasma and urine samples from psychiatric patients. Journal of Chromatography, B: Biomedical Applications 1984; 308: 199-208.
82. Ohman D, Carlsson B and Norlander B. On-line extraction using an alkyl-diol silica precolumn for racemic citalopram and its metabolites in plasma-results compared with solid-phase extraction methodology. Journal of Chromatography, B 2001; 753: 365-373.
83. Olesen OV and Linnet K. Simplified high-performance liquid chromatographic method for the determination of citalopram and desmethylcitalopram in serum without interference from commonly used psychotropic drugs and their metabolites. Journal of Chromatography, B: Biomedical Applications 1996; 675: 83-88.
84. Overo KF. Preliminary studies of the kinetics of citalopram in man. European Journal of Clinical Pharmacology 1978; 14: 69-73.
85. Overø KF. Fluorescence assay of citalopram and its metabolites in plasma by scanning densitometry of thin-layer chromatograms. Journal of Chromatography, B: Biomedical Sciences and Applications 1981; 224: 526-531.
86. Paterson S, Cordero R, McCulloch S and Houldsworth P. Analysis of urine for drugs of abuse using mixed-mode solid-phase extraction and gas chromatography-mass spectrometry. Annals of Clinical Biochemistry 2000; 37: 690-700.
87. Paterson S, Cordero R and Burlinson S. Screening and semi-quantitative analysis of postmortem blood for basic drugs using gas chromatography/ion trap mass spectrometry. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2004; 813: 323-330.
88. Peters FT, Drvarov O, Lottner S, Spellmeier A, Rieger K, Haefeli WE and Maurer HH. A systematic comparison of four different workup procedures for systematic toxicological analysis of urine samples using gas chromatography-mass spectrometry. Analytical and Bioanalytical Chemistry 2009; 393: 735-745.
89. Pistos C, Panderi I and Atta-Politou J. Liquid chromatography-positive ion electrospray mass spectrometry method for the quantification of citalopram in human plasma. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2004; 810: 235-244.
90. Pucci V, Fanali S, Sabbioni C and Raggi MA. Separation of five recently commercialized selective serotonin reuptake inhibitor antidepressants by capillary electrophoresis. Journal of Separation Science 2002; 25: 1096-1100.
91. Raggi MA, Pucci V, Mandrioli R, Sabbioni C and Fanali S. Determination of recent antidepressant citalopram in human plasma by liquid chromatography-fluorescence detection. Chromatographia 2003; 57: 273-278.
92. Raman B, Sharma Brajesh A, Ghugare Pradeep D, Karmuse Pravin P and Kumar A. Semi-preparative isolation and structural elucidation of an impurity in citalopram by LC/MS/MS. Journal of Pharmaceutical and Biomedical Analysis 2009; 50: 377-383.
93. Rampono J, Kristensen JH, Hackett LP, Paech M, Kohan R and Ilett KF. Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants. British Journal of Clinical Pharmacology 2000; 50: 263-268.
94. Rao RN, Raju AN and Narsimha R. Isolation and characterization of degradation products of citalopram and process-related impurities using RP-HPLC. Journal of Separation Science 2008; 31: 1729-1738.
95. Rasmussen KE, Pedersen-Bjergaard S, Krogh M, Grefslie Ugland H and Gronhaug T. Development of a simple in-vial liquid-phase microextraction device for drug analysis compatible with capillary gas chromatography, capillary electrophoresis and high-performance liquid chromatography. Journal of Chromatography, A 2000; 873: 3-11.
96. Reymond P, Amey M, Souche A, Lambert S, Konrat H, Eap CB and Baumann P. Determination of plasma levels of citalopram and its demethylated and deaminated metabolites by gas chromatography and gas chromatography-mass spectrometry. Journal of Chromatography, Biomedical Applications 1993; 616: 221-228.
97. Rocha A, Marques MP, Coelho EB and Lanchote VL. Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: application to pharmacokinetics. Chirality 2007; 19: 793-801.
98. Rochat B, Amey M and Baumann P. Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients by chiral reverse-phase liquid chromatography. Therapeutic Drug Monitoring 1995a; 17: 273-279.
99. Rochat B, Amey M, Van Gelderen H, Testa B and Baumann P. Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC. Chirality 1995b; 7: 389-395.
100. Rop PP, Viala A, Durand A and Conquy T. Determination of citalopram, amitriptyline and clomipramine in plasma by reversed-phase high-performance liquid chromatography. Journal of Chromatography, Biomedical Applications 1985; 338: 171-178.
101. Rop PP, Durand A, Viala A and Joergensen A. Simultaneous determination of citalopram, monodesmethylcitalopram and didesmethylcitalopram in plasma by high-performance liquid chromatography after column extraction. Journal of Chromatography, Biomedical Applications 1990; 527: 226-232.
102. Salgado-Petinal C, Lamas JP, Garcia-Jares C, Llompart M and Cela R. Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry. Analytical and Bioanalytical Chemistry 2005; 382: 1351-1359.
103. Sanchez-Ortega A, Unceta N, Gomez-Caballero A, Sampedro MC, Akesolo U, Goicolea MA and Barrio RJ. Sensitive determination of triazines in underground waters using stir bar sorptive extraction directly coupled to automated thermal desorption and gas chromatography-mass spectrometry. Analytica Chimica Acta 2009; 641: 110-116.
104. Satana E, Uysal UD, Goger N and Tuncel M. Capillary electrophoretic determination of citalopram in pharmaceutical tablets and serum. Chromatographia 2006; 64: 317-320.
105. Satana E, Ertas N and Goeger NG. Determination of citalopram using flow injection-solid phase extraction with spectrofluorometric detection. Chromatographia 2007; 66: S75-S79.
106. Sauvage F-L, Saint-marcoux F, Duretz B, Deporte D, Lachatre G and Marquet P. Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry. Clinical Chemistry 2006a; 52: 1735-1742.
107. Sauvage FL, Gaulier JM, Lachatre G and Marquet P. A fully automated turbulent-flow liquid chromatography-tandem mass spectrometry technique for monitoring antidepressants in human serum. Therapeutic Drug Monitoring 2006b; 28: 123-130.
108. Schultz MM and Furlong ET. Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. Analytical Chemistry 2008; 80: 1756-1762.
109. Schultz MM, Furlong ET, Kolpin DW, Werner SL, Schoenfuss HL, Barber LB, Blazer VS, Norris DO and Vajda AM. Antidepressant pharmaceuticals in two US effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environmental Science & Technology 2010; 44: 1918-1925.
110. Silva BJG, Queiroz RHC and Queiroz MEC. Simultaneous determination of nontricyclic antidepressants in human plasma by solid-phase microextraction and liquid chromatography (SPME-LC). Journal of Analytical Toxicology 2007; 31: 313-320.
111. Silva BJG, Lancas FM and Queiroz MEC. In-tube solid-phase microextraction coupled to liquid chromatography (in-tube SPME/LC) analysis of nontricyclic antidepressants in human plasma. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2008; 862: 181-188.
112. Singh SS, Shah H, Gupta S, Jain M, Sharma K, Thakkar P and Shah R. Liquid chromatography-electrospray ionisation mass spectrometry method for the determination of escitalopram in human plasma and its application in bioequivalence study. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 2004; 811: 209-215.
113. Skibinski R and Misztal G. Determination of citalopram in tablets by HPLC, densitometric HPTLC, and videodensitometric HPTLC methods. Journal of Liquid Chromatography & Related Technologies 2005; 28: 313-324.
114. Smalley J, Xin B and Olah TV. Increasing high-throughput Discovery bioanalysis using automated selected reaction monitoring compound optimization, ultra-high-pressure liquid chromatography, and single-step sample preparation workflows. Rapid Communications in Mass Spectrometry 2009; 23: 3457-3464.
115. Smyth WF, Leslie JC, McClean S, Hannigan B, McKenna HP, Doherty B, Joyce C and O'Kane E. The characterisation of selected antidepressant drugs using electrospray ionisation with ion trap mass spectrometry and with quadrupole time-of-flight mass spectrometry and their determination by high-performance liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2006; 20: 1637-1642.
116. Song SM, Marriott P, Kotsos A, Drummer OH and Wynne P. Comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry (GC * GC-TOFMS) for drug screening and confirmation. Forensic Science International 2004; 143: 87-101.
117. Su HL and Hsieh YZ. Using cation-selective exhaustive injection and sweeping micellar electrokinetic chromatography to determine selective serotonin reuptake inhibitors. Journal of Chromatography, A 2008; 1209: 253-259.
118. Sun CR, Xu H, Pan YJ, Shen ZQ and Wang DH. Characterization of the trace-level impurities in the bulk drug citalopram by high-performance liquid chromatography/tandem multistage mass spectrometry. Rapid Communications in Mass Spectrometry 2007; 21: 2889-2894.
119. Sungthong B, Jac P and Scriba GKE. Development and validation of a capillary electrophoresis method for the simultaneous determination of impurities of escitalopram including the R-enantiomer. Journal of Pharmaceutical and Biomedical Analysis 2008; 46: 959-965.
120. Titier K, Castaing N, Scotto-Gomez E, Pehourcq F, Moore N and Molimard M. High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose. Therapeutic Drug Monitoring 2003; 25: 581-587.
121. Tournel G, Houdret N, Hedouin V, Deveaux M, Gosset D and Lhermitte M. High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum. Journal of Chromatography, B 2001; 761: 147-158.
122. Trachta G, Schwarze B, Sagmuller B, Brehm G and Schneider S. Combination of high-performance liquid chromatography and SERS detection applied to the analysis of drugs in human blood and urine. Journal of Molecular Structure 2004; 693: 175-185.
123. Unceta N, Gomez-Caballero A, Sanchez A, Millan S, Sampedro MC, Goicolea MA, Salles J and Barrio RJ. Simultaneous determination of citalopram, fluoxetine and their main metabolites in human urine samples by solid-phase microextraction coupled with high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 2008; 46: 763-770.
124. Unceta N, Sampedro MC, Bakar NKA, Gomez-Caballero A, Goicolea MA and Barrio RJ. Multi-residue analysis of pharmaceutical compounds in wastewaters by dual solid-phase microextraction coupled to liquid chromatography electrospray ionization ion trap mass spectrometry. Journal of Chromatography, A 2010a; 1217: 3392-3399.
125. Unceta N, Ugarte A, Sanchez A, Gomez-Caballero A, Goicolea MA and Barrio RJ. Development of a stir bar sorptive extraction based HPLC-FLD method for the quantification of serotonin reuptake inhibitors in plasma, urine and brain tissue samples. Journal of Pharmaceutical and Biomedical Analysis 2010b; 51: 178-185.
126. van Harten J. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clinical Pharmacokinetics 1993; 24: 203-220.
127. Vasskog T, Berger U, Samuelsen PJ, Kallenborn R and Jensen E. Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromso, Norway. Journal of Chromatography, A 2006; 1115: 187-195.
128. Vasskog T, Anderssen T, Pedersen-Bjergaard S, Kallenborn R and Jensen E. Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway. Journal of Chromatography, A 2008; 1185: 194-205.
129. Vendelin-Olesen O, Plougmann P and Linnet K. Determination of nortriptyline in human serum by fully automated solid-phase extraction and on-line high-performance liquid chromatography in the presence of antipsychotic drugs. Journal of Chromatography, B: Biomedical Sciences and Applications 2000; 746: 233-239.
130. Wang N-S and Lemmer B. Determination of citalopram in plasma and brain tissue of the rat by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography, Biomedical Applications 1989; 488: 492-497.
131. Waschgler R, Hubmann MR, Conca A, Moll W and Konig P. Simultaneous quantification of citalopram, clozapine, fluoxetine, norfluoxetine, maprotiline, desmethylmaprotiline and trazodone in human serum by HPLC analysis. International Journal of Clinical Pharmacology and Therapeutics 2002; 40: 554-559.
132. Wille SMR, Maudens KE, Van Peteghem CH and Lambert WEE. Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis. Journal of Chromatography, A 2005; 1098: 19-29.
133. Wille SMR, Van Hee P, Neels HM, Van Peteghem CH and Lambert WE. Comparison of electron and chemical ionization modes by validation of a quantitative gas chromatographic-mass spectrometric assay of new generation antidepressants and their active metabolites in plasma. Journal of Chromatography, A 2007; 1176: 236-245.
134. Willetts J, Lippa A and Beer B. Clinical development of citalopram. Journal of Clinical Psychopharmacology 1999; 19: 36S-46S.
135. Zheng ZC, Jamour M and Klotz U. Stereoselective HPLC-assay for citalopram and its metabolites. Therapeutic Drug Monitoring 2000; 22: 219-224.